ContractWarrant Agreement • July 10th, 2003 • Oncure Medical Corp • Services-offices & clinics of doctors of medicine • Delaware
THIS WARRANT AND ANY SHARES ACQUIRED UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY APPLICABLE STATE SECURITIES LAWS AND MAY NOT BE SOLD OR TRANSFERRED WITHOUT COMPLIANCE WITH THE REGISTRATION OR QUALIFICATION PROVISIONS OF APPLICABLE FEDERAL AND STATE SECURITIES LAWS OR APPLICABLE EXEMPTIONS THEREFROM. THIS WARRANT AND ANY SHARES ACQUIRED UPON THE EXERCISE OF THIS WARRANT ARE SUBJECT TO THE TERMS OF A STOCKHOLDERS AGREEMENT DATED AS OF THE DATE HEREOF AMONG ONCURE MEDICAL CORP. AND CERTAIN OF ITS STOCKHOLDERS
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • July 10th, 2003 • Oncure Medical Corp • Services-offices & clinics of doctors of medicine • Delaware
This Registration Rights Agreement (the “Agreement”) is entered into as of June 30, 2003, among OnCure Medical Corp., a Delaware corporation (the “Company”); the persons and/or entities listed as Series A Investors on Schedule I attached hereto (the “Series A Investors”); the persons and/or entities listed as Series B Investors on Schedule I (the “Series B Investors”); and the persons and/or entities listed as Series C-1 Investors on Schedule I (the “Series C-1 Investors”). The names and addresses of all parties to this Agreement are set forth on Schedule I.
SECURITIES PURCHASE AGREEMENT among ONCURE MEDICAL CORP. U.S. CANCER CARE, INC. USCC ACQUISITION CORP. USCC FLORIDA ACQUISITION CORPORATION USCC HEALTHCARE MANAGEMENT CORP. MICA FLO II, INC. JAXPET/POSITECH, L.L.C. POINTE WEST ONCOLOGY, LLC JAX PET...Securities Purchase Agreement • July 10th, 2003 • Oncure Medical Corp • Services-offices & clinics of doctors of medicine • Delaware
OnCure Medical Corp., a Delaware corporation, and each of its Subsidiaries signatory hereto hereby agree with Laurel Holdings II, L.L.C., as follows:
JOINT REPORTING AGREEMENTJoint Reporting Agreement • July 10th, 2003 • Oncure Medical Corp • Services-offices & clinics of doctors of medicine
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13D need be filed with respect to the ownership by each of the undersigned of shares of common stock, par value $0.001 per share, of OnCure Medical Corp., a Delaware corporation, and that all subsequent amendments to this statement on Schedule 13D shall be filed on behalf of each of the undersigned without the necessity of filing additional joint acquisition statements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him contained herein, but shall not be responsible for the completeness and accuracy of the information concerning the other persons, except to the extent that he knows or has reason to believe that such information is inaccurate.
STOCKHOLDERS AGREEMENTStockholders Agreement • July 10th, 2003 • Oncure Medical Corp • Services-offices & clinics of doctors of medicine • Delaware
This Stockholders Agreement (the “Agreement”) is entered into as of June 30, 2003, among (i) OnCure Medical Corp., a Delaware corporation (the “Company”); (ii) the persons and/or entities listed as Common Holders on Schedule I and any additional person and/or entity that, after the date hereof, acquires shares of Common Stock (defined below) and join in and become a party to this Agreement by executing and delivering to the Company an Instrument of Accession in the form of Schedule II hereto (collectively, the “Common Stockholders”); (iii) the persons and/or entities listed as Series A Stockholders on Schedule I attached hereto (the “Series A Stockholders”); (iv) the persons and/or entities listed as Series B Stockholders on Schedule I (the “Series B Stockholders”); and (v) the persons and/or entities listed as Series C-1 Stockholders on Schedule I (the “Series C-1 Stockholders”). The names and addresses of all parties to this Agreement are set forth on Schedule I.
